Join Seqirus, BESIX Watpac, and ICN Victoria for this online industry briefing on Tuesday June 22nd for interested suppliers, contractors, registered social enterprises and Aboriginal businesses.

Seqirus, a subsidiary of CSL, are developing a new manufacturing facility in Tullamarine to produce seasonal and pandemic flu vaccines. The new facility will comprise manufacturing areas, warehousing, central plant and utilities, office, administration and quality assurance testing spaces.

Join Seqirus, BESIX Watpac, and ICN Victoria for this online industry briefing on Tuesday June 22nd for interested suppliers, contractors, registered social enterprises and Aboriginal businesses.

This major project will require engagement of building and construction trades including:

• Civil and external works,
• Building structure and envelope,
• Building services (Mechanical, Electrical, Hydraulic and Process Services)
• Fit Out and Finishes Trades

As a campus style development the project comprises a number of buildings across the 14.4 Ha site with construction intended to commence mid 2021 and be completed in 2024.